Your session is about to expire
← Back to Search
Tricuspid Valve Repair System
Device: TriCinch Coil System treatment for Valvular Heart Disease
N/A
Waitlist Available
Research Sponsored by 4Tech Cardio Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days, three (3), six (6), twelve (12) and twenty-four (24) months post procedure
Awards & highlights
No Placebo-Only Group
Summary
The primary objective of the study is to generate feasibility safety and performance data for the 4Tech TriCinch Coil System in symptomatic patients suffering from moderate to severe functional tricuspid regurgitation with annular dilatation. The TriCinch Coil System is a percutaneous catheter-based medical device for tricuspid valve repair.
Eligible Conditions
- Valvular Heart Disease
- Tricuspid Regurgitation
- Heart Valve Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 days, three (3), six (6), twelve (12) and twenty-four (24) months post procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days, three (3), six (6), twelve (12) and twenty-four (24) months post procedure
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Echocardiographic changes in Effective Regurgitant Orifice Area (EROA) compared to Baseline
Functional changes as compared to Baseline for New York Heart Association (NYHA) classification
Quality of Life evaluation using the Kansas City Cardiomyopathy Questionnaire (KCCQ).
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Device: TriCinch Coil System treatmentExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
4Tech Cardio Ltd.Lead Sponsor
2 Previous Clinical Trials
42 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger